Načítá se...
Evaluation of a SARS-CoV-2 lateral flow assay using the plaque reduction neutralization test
As new tests and technologies advance our understanding and diagnostic capabilities of the severe acute respiratory syndrome coronavirus 2 and the coronavirus disease 2019, they must be appropriately validated to make sure test performance is following manufacturer claims. In this study, we evaluate...
Uloženo v:
| Vydáno v: | Diagn Microbiol Infect Dis |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier Inc.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7562965/ https://ncbi.nlm.nih.gov/pubmed/33130510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.diagmicrobio.2020.115248 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|